Cancer Immunosurveillance Comes of Age
As oncologists learn to target the immune response to “self and non-self,” a delicate therapy balance will eventually be achieved with predictable outcomes, benefits, and toxicity in the fight against cancer.
Clifford Pukel, MD
Clifford Pukel, MD is a board certified medical oncologist and CEO of the Cancer Vaccine Cancer Immunotherapy (CVCI) foundation. He is an assistant clinical professor of medicine at the University of Wisconsin Medical School, where he lectures on various topics with particular interest in the history of cancer. His most recent book, Cancer and the Human Condition, was published in 2010.
